GlassScriptPhysician profile
Travis M Loven
NPI 1609074913
$3,883.72
in general payments reported to CMS, 2019-2025
19 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $957 · 2020: $206 · 2021: $720 · 2022: $329 · 2023: $1,007 · 2024: $416 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372 · Travel and Lodging: $281 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.43 |
| Travel and Lodging | $281.35 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,263.36 | 2019-2024 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $568.96 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $310.66 | 2019-2024 | |
| Sight Sciences, INC. | $224.70 | 2019-2022 | |
| Rxsight INC | $214.09 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Coopervision INC. | $193.91 | 2021-2024 | Myday Contact Lens, Ortho-K Contact Lens, Synergeyes Contact Lens |
| Bausch & Lomb Americas INC. | $142.84 | 2024 | Miebo, Xiidra |
| Apellis Pharmaceuticals, INC. | $124.40 | 2025 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $124.40 | 2025 | Xdemvy |
| Astellas Pharma US INC | $123.76 | 2023 | Izervay |
| Glaukos Corporation | $111.91 | 2021 | |
| Kala Pharmaceuticals, INC. | $103.03 | 2021 | |
| Ivantis, INC | $93.17 | 2021 | |
| Ocular Therapeutix, INC. | $86.72 | 2021 | |
| Abb Con-Cise Optical Group LLC | $69.18 | 2024 | Spectacle Lenses, Contact Lens |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $68.90 | 2021 | |
| Abbvie INC. | $23.56 | 2022 | |
| Optos, INC. | $21.81 | 2019 | |
| Oyster Point Pharma, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Loven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.